AGP Executive Report
Last update: 6 hours agoHemp Rules: A federal ban on synthetic hemp-derived cannabinoids is due to take effect Nov. 12, while hemp businesses say new rules are already taking a toll. The measure targets synthetic cannabinoids, not CBD generally. Medical Research: A study reports sustained pain relief and reduced opioid use among chronic pain patients receiving medical cannabis. In mice, tolerance to CBN, a popular sleep aid, developed within three days. CBD Guidance: New consumer guides explain CBD safety, quality and legality in the UK, with a separate 2026 guide covering Iowa’s rules. Market Access: Kentucky’s new Prestonsburg dispensary brings medical cannabis closer to about 1,000 registered patients in eastern Kentucky; Alabama also expects two dispensaries to open. Global Policy: South Africa’s cannabis and hemp market is estimated at R16 billion or more than R25 billion, but the wide range highlights how hard it is to measure a sector shaped by unclear rules and informal sales.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
